TheraVet announced the commercial launch of its BIOCERA-VET products in Germany. With a total pet population of 27 million (of which 10.3 million dogs and 16.7 million cats) and a pet ownership of 47%1, Germany is the dominating companion animal market in Europe. Driven by the growing number of mixed-breed dogs in Germany, demand for animal health products and services is expected to increase significantly, with an estimated average annual growth rate of 4.5% over the next 6 years (2024-2029)2. To support this launch, the Company is attending the Leipzig Veterinary Congress, the biggest event for veterinary medicine in the German-speaking area, taking place in Leipzig from January 18th to 20th.

The last edition gathered 5,600 attendees coming from Germany and abroad. The Company assists to this event along with AWEX (Wallonia Export & Investment Agency) in the context of a mission dedicated to the Animal Health. The Company will also have the chance to present the product line during 2 open lectures: first, on January 18th dedicated to on BIOCERA-VET OSTEOSARCOMA, a new solution in limb-sparing management in canine osteosarcoma and, a second on January 19th on BIOCERA-Vet®?

BONE SURGERY line.